TI
PMVP icon

Trexquant Investment’s PMV Pharmaceuticals PMVP Stock Holding History

Trexquant Investment’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-68,202
Closed -$419K – 1713
2023
Q3 		$419K Buy
+68,202
New +$469K 0.01% 1092
2023
Q2 		– Sell
-44,144
Closed -$211K – 1722
2023
Q1 		$211K Buy
44,144
+17,898
+68% +$126K 0.01% 1303
2022
Q4 		$228K Sell
26,246
-23,959
-48% -$255K 0.01% 1197
2022
Q3 		$597K Buy
+50,205
New +$725K 0.02% 743
2022
Q1 		– Sell
-13,264
Closed -$306K – 1640
2021
Q4 		$306K Buy
+13,264
New +$320K 0.02% 911

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Trexquant Investment's PMVP Position: Q4 2023 in Review

Trexquant Investment sold out of PMV Pharmaceuticals (PMVP) in Q4 2023, closing a stake of 68,202 shares — an estimated $419K sold.

Trexquant Investment first reported a position in PMVP in Q4 2021 and held it in 5 quarters. The position peaked at $597K in Q3 2022. 98 funds tracked by Wall St. Rank hold PMVP as of Q4 2023.

  • Trexquant Investment reported no remaining PMV Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Trexquant Investment sold 68,202 PMV Pharmaceuticals shares in Q4 2023, an estimated $419K.
  • Trexquant Investment first reported a position in PMV Pharmaceuticals in Q4 2021 and held it in 5 quarters.
  • Trexquant Investment's PMV Pharmaceuticals position peaked at $597K in Q3 2022.
  • 98 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2023.

Based on Trexquant Investment's 13F filing for Q4 2023, filed 9 Feb 2024.